ILMN


ILMN: Illumina to Announce Fourth Quarter and Fiscal Year 2014 Financial Results on Tuesday, January 27, 2015

(BUSINESS WIRE)–Jan. 13, 2015– Illumina, Inc.

Stock Update (NASDAQ:ILMN): Lockheed Martin and Illumina to Collaborate on Developing Genomics Solutions to Improve Public Health and Wellness

(BUSINESS WIRE)–Jan. 12, 2015– Lockheed Martin (NYSE:LMT) and Illumina, Inc.

Stock Update (NASDAQ:ILMN): Illumina Expands World’s Most Comprehensive Next-Generation Sequencing Portfolio

(BUSINESS WIRE)–Jan. 12, 2015– Illumina, Inc.

Wedbush Comments On Illumina Following ‘Poorly Diligenced GenomeWeb Article’ Release

Wedbush analyst Zarak Khurshid maintained an Outperform rating on Illumina (NASDAQ:ILMN) with a $200 price target, following the release of GenomeWeb article entitled, “Undercover …

Oppenheimer Maintains Perform On Illumina Following 3Q14 Results

In a research report issued to investors today, Oppenheimer analyst Bret Jones maintained a Perform rating on Illumina (NASDAQ:ILMN) following the company’s fourth-quarter …

William Blair Maintains Outperform On Illumina Following Investor Meeting With Management

In a research report issued today, William Blair analyst Amanda Murphy reiterated an Outperform rating on Illumina (ILMN) with a $200 fair value, following recent investor meeting with CEO Jay Flatley, …

William Blair Reiterates Outperform On Illumina Following Survey Findings

In a research report issued yesterday, William Blair analyst Amanda Murphy reiterated an Outperform rating on Illumina (ILMN), with a $200 fair value. The call comes following a survey that shows …

Checks Suggest Illumina Has Won An Exclusive Competitive Contract with Progenity, Says Wedbush

In a research note issued today, Wedbush analyst Zarak Khurshid reiterated coverage with a “Neutral” rating on Illumina Inc. (ILMN) and a price target of $155.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts